CPhI’s inaugural event in the North American market breathed new life into InformEx as more than 7000 people gathered alongside more than 550 exhibitors in central Philadelphia on 16-18 May. We met with Angelini, Cambrex, CordenPharma, Daikin, Flamma, Hovione, PCI Pharma Services, Navin Fluorine, Norac Pharma, Optima Chemical, REACHLaw, Robinson Brothers, SOCMA, Vertellus, Zeon and others, to discuss news, views and opportunities in North America.
The pilot plan for a Marketing Authorization Holder (MAH) system is a revolutionary process in the development of biopharmaceutical innovation in China. As well as making it easier for China’s biotechs to progress their own products, the scheme allows overseas drug license holders to use contract facilities in China, enabling easier access to the market. China is an emerging giant in the pharma sector, with around 6,500 pharmaceutical manufacturing companies producing 1,500 types of APIs. The biggest production volumes are for Vitamins C & E, penicillin and paracetamol. In addition, there are 16,000 medical device and equipment manufacturing companies, which produce about 3,000 kinds of products such as MRI and CT.
Gelest has unveiled its new SiBRID TM-31, a personal care silicone vehicle with solubility and volatility characteristics similar to cyclomethicone (D5).
Financial results for the first quarter of 2017 show that sales and earnings are above last year’s first quarter at BASF (up 19%), Clariant (9%), Dow Chemical (24%) and Wacker (8%), providing further evidence for an upturn in the global chemicals industry.
The global need to reduce the use of antibiotics in animal husbandry has fuelled the search for alternatives. Now, the Perstorp Group has introduced ProPhorce Valerins – glycerol esters of valeric acid to be used in feed to promote animal performance.
Published: May 19, 2017